<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2014-06-17 15:58:53NCI-designated Cancer Center University of Pittsburgh Cancer Institute Duke Cancer Institute Cancer research National Cancer Institute James L. Gulley Edison Liu Medicine Cancer organizations Oncology |
Add to Reading List |
NATIONAL CANCER INSTITUTE | MD Anderson, MedImmune join forces on immunotherapy Friday, March 14, 2014 Jim Allison, Ph.D., is executive director of the immunotherapy platform. MD Anderson and MedImmune, the global biologics research and developmentDocID: 15NcO - View Document |
| Collaboration with Johnson & Johnson Innovation announced Tuesday, January 21, 2014 MD Anderson will collaborate with Johnson & Johnson Innovation, LLC, and its affiliate Janssen Biotech Inc., to develop immunology-basedDocID: 15MxD - View Document |
| Microsoft Word - ScientificLeadershipBiosFinal042409.docDocID: 14qIu - View Document |
| Published in June[removed]Clinical Trial Solutions Copyright 2014 by PharmaLinx LLCDocID: P6St - View Document |
| restifo-CD8_TcellDiff_v02DocID: GAsV - View Document |